SOBR Safe closes $2.5M financing via 18% OID convertible debenture and warrants with healthcare fund

SOBR Safe, Inc.

Received $2.5M; issued convertible debenture with principal $3,048,780.50 (18% original issue discount).
Debenture convertible at lesser of 100% of prior close or 75% of 5-day VWAP; matures March 27, 2022, no interest unless default.
Warrants to purchase 1,219,512 shares at $2.00/share for 5 years; drops to $1.00 on default; cashless exercise limited.
Proceeds to fund pilot testing and commercial manufacturing starting October 2021; Alexander Capital as placement agent.
Registration rights agreement requires filing within 6 months; warrants cashless only if registration fails after 6 months.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.